Navigation Links
China Biologic to Report Second Quarter 2014 Financial Results
Date:7/29/2014

BEIJING, July 29, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release second quarter 2014 financial results on Tuesday, August 5, 2014 after the market closes.

The Company's management will hold a conference call at 8:00 a.m. ET on Wednesday, August 6, 2014, which is 8:00 p.m., Beijing Time on August 6, 2014, to discuss second quarter 2014 results. Listeners may access the call by dialing:

US:                                                       1 877 870 4263 
International:                                        1 412 317 0790   
Hong Kong:                                          800 905 945 
China:                                                  400 120 1203
Passcode:                                            China Biologic Products Inc.                   

A telephone replay will be available one hour after the conclusion of the conference call through 9:00 a.m., Eastern Time on August 13, 2014. The dial-in details are:

US:                                                        1 877 344 7529
International:                                         1 412 317 0088    
Passcode:                                             10050434                      

A live and archived webcast of the conference call will be available through the Company's investor relations website at http://chinabiologic.investorroom.com/.

About China Biologic Products, Inc.

China Biologic is a leading plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 different dosages of plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and inoculation centers, as well as distributors, in China. For additional information, please see the Company's website www.chinabiologic.com .

Contact:

China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com

ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: william.zima@icrinc.com


'/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China
2. Orthopedic Instrument Industry in China Markets Forecast to 2015
3. EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
4. CareFusion Completes Vital Signs Acquisition In U.S., China
5. China Antidiabetic Drug Market 2014 Analysis & 2018 Forecasts
6. Research Report on Global and China Aerosol Industry, 2013-2017
7. Use of Roches Herceptin Among HER2+ Gastric Cancer Patients May Double in China Over the Next Three Years
8. China Pharmaceutical Guidebook: (2013 Edition) Latest Chinese Regulations for Imported Drug Registration
9. Surveyed Oncologists Indicate that the Use of Biomarker Testing is Increasing Rapidly in Non-Small-Cell Lung Cancer in China and South Korea
10. China Feed Additives Industry Report, 2012-2015
11. Lucintel Analysis: Medical Reforms and Aging Population to Offer Significant Growth Opportunities to China Oxygen Cylinders Industry Players
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), ... labor and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding ... the hospital and decide to donate. , “Women’s Hospital at Renaissance has been ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
Breaking Medicine News(10 mins):